The firm is a joint venture between BioAccel and Imprimatur Capital. It makes seed investments in life science, information technology, telecommunications, and clean energy companies.
Henislie Headquarter Location
9320 Wilshire Boulevard Suite 306
Beverly Hills, California, 90212,
1 Team Member
Henislie has 1 team member, including current Chief Executive Officer, Andrew Bottomley.